China Pharma Holdings (CPHI) Receivables - Other (2010 - 2026)
China Pharma Holdings (CPHI) posted Receivables - Other of $66,627 for Q2 2026, up 37.8% from $48,361 a year earlier and up 8.1% from the prior quarter.
Powered by 
Analysis
China Pharma Holdings (CPHI) Receivables - Other (2010 - 2026) Analysis & Trends
At the end of FY2025, China Pharma Holdings' Receivables - Other came in at $49,261, up 62.7% from FY2024.
- Annual Receivables - Other shows a five-year compound annual growth rate of -41.8% (FY2020 to FY2025).
- In prior years, China Pharma Holdings' Receivables - Other was $30,286 in FY2024 (-80.8%), $157,944 in FY2023 (-85.9%), $1.12 million in FY2022 (-21.3%) and $1.43 million in FY2021 (+92.5%).
- The Q2 2026 figure stands as the highest quarterly Receivables - Other since Q4 2023.
- On a year-over-year basis, Receivables - Other has increased in each of the last six quarters, with growth averaging 32.5% over the last eight quarters.
- The strongest year-over-year quarter for Receivables - Other in the past five years was Q4 2023, with growth of 442.0%; the weakest was Q4 2022, with a decline of 98.0%.
- According to Business Quant data, Receivables - Other for the three prior quarters was $61,657 (Q1 2026), $49,261 (Q4 2025) and $61,275 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | China Pharma Holdings | 29.58 Mn | 28.46 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66,627.00 |
| Mar 31, 2026 | 61,657.00 |
| Dec 31, 2025 | 49,261.00 |
| Sep 30, 2025 | 61,275.00 |
| Jun 30, 2025 | 48,361.00 |
| Mar 31, 2025 | 39,046.00 |
| Dec 31, 2024 | 30,286.00 |
| Sep 30, 2024 | 46,553.00 |
| Jun 30, 2024 | 28,660.00 |
| Mar 31, 2024 | 32,220.00 |
| Dec 31, 2023 | 157,944.00 |
| Sep 30, 2023 | 28,929.00 |
| Dec 31, 2022 | 29,139.00 |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 1.15 Mn |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 1.70 Mn |
| Jun 30, 2021 | 1.47 Mn |
| Mar 31, 2021 | 829,279.00 |
API Access
China Pharma Holdings Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=CPHI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();